C. Challeton-de Vathaire
Institut de radioprotection et de sûreté nucléaire
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by C. Challeton-de Vathaire.
Radiation Protection Dosimetry | 2016
G. Etherington; Philippe Bérard; E. Blanchardon; B. Breustedt; C. M. Castellani; C. Challeton-de Vathaire; A. Giussani; D. Franck; M. A. Lopez; J. W. Marsh; D. Nosske
The TECHREC project, funded by the European Commission, will provide Technical Recommendations for Monitoring Individuals for Occupational Intakes of Radionuclides It is expected that the document will be published by the European Commission as a report in its Radiation Protection Series during 2016. The project is coordinated by the European Radiation Dosimetry Group (EURADOS) and is being carried out by members of EURADOS Working Group 7 (Internal Dosimetry). This paper describes the aims and purpose of the Technical Recommendations, and explains how the project is organised.
Applied Radiation and Isotopes | 2012
D. Franck; J. Bernière; D. Viltard; F. Parre; C. Challeton-de Vathaire; M. Agarande
To provide medical surveillance of workers exposed to risk of internal contamination, IRSN (French Institute for Radiological Protection and Nuclear Safety) has developed two mobile laboratories for on-site monitoring. The laboratories are unique in Europe. They meet the new radiation protection requirements for nuclear medicine departments and radiological emergency response. Details of the design, calibration procedures and performance characteristics of these systems in measurements of various types of organs (thyroid, lung and whole body) are described. The sensitivity of the measurements is very close to that achieved in a heavily shielded stationary laboratory.
Revue D Epidemiologie Et De Sante Publique | 2016
E. Cléro; L. Marie; C. Challeton-de Vathaire; D. Laurier; A. Rannou
BACKGROUND At the request of French public authorities, the Institute of Radiological Protection and Nuclear Safety has assessed the radiological situation of a house built on uranium ore residues in Haute-Vienne and the health risks induced from exposure to radon for all occupants. Classified as a lung carcinogen by the World Health Organization, radon is a proven cause of lung cancer in case of regular inhalation over a long period, and the risk increases with cumulative exposure. METHODS Radon exposure was reconstructed for various standard profiles of house occupancy. A risk model derived from a European epidemiological study was used to calculate the lifetime probability of death from lung cancer according to these standard profiles. RESULTS Risk assessment of the occupants of the house highlighted the following main findings. For a resident school child having been exposed to radon from birth to the age of 7, the lifetime relative risk (LRR) was estimated at 5. For last adult and young adult residents having lived more than 10years in the house, the probability of death from lung cancer was in the same order of magnitude as that of a regular cigarette smoker, with a LRR from 10 to 13 and a lifetime probability of death from lung cancer between 3 and 4%. If these individuals smoked regularly, in addition to being exposed to radon, this probability would be between 6 and 32% (supposing an additive or multiplicative interaction). CONCLUSION For former occupants (non-smokers) having been exposed 10years during childhood, the LRR was two-fold lower. For children having been in day care in the house, the increased probability of death from lung cancer was low, with a LRR lower than 2. Supposing, as in adults, that the risk decreases beyond 30years after the end of radon exposure, the increase was almost zero for former occupants exposed during childhood and during day care, with a LRR close to 1.
Radiation Protection Dosimetry | 2007
M. A. Lopez; G. Etherington; C. M. Castellani; D. Franck; C. Hurtgen; J. W. Marsh; D. Nosske; H. Doerfel; A. Andrasi; M. R. Bailey; Imre Balásházy; Paolo Battisti; P. Bérard; V. Berkowski; A. Birchall; E. Blanchardon; Y. Bonchuk; L. de Carlan; Marie Claire Cantone; C. Challeton-de Vathaire; R. Cruz-Suarez; K. Davis; D. Dorrian; A. Giussani; B. Le Guen; A. Hodgson; Jean-René Jourdain; V. Koukouliou; A. Luciani; I. Malatova
Radiation Protection Dosimetry | 2007
A. Mièle; N. Blanchin; P. Raynaud; B. Quesne; J. M. Giraud; R. Fottorino; P. Bérard; E. Ansoborlo; D. Franck; E. Blanchardon; C. Challeton-de Vathaire; L. Lebaron-Jacobs; J. L. Poncy; J. Piechowski; P. Fritsch
Radiation Protection Dosimetry | 2007
R. Cruz Suárez; P. Bérard; J. D. Harrison; D. R. Melo; D. Nosske; Michael G. Stabin; C. Challeton-de Vathaire
Radiation Protection Dosimetry | 2005
E. Blanchardon; C. Challeton-de Vathaire; P. Boisson; D. Célier; J.-C. Martin; S. Cassot; G. Herbelet; D. Franck; Jean-René Jourdain; A. Biau
Radioprotection | 2018
Eric Samson; Klervi Leuraud; Estelle Rage; S. Caër-Lorho; Sophie Ancelet; E. Cléro; Ségolène Bouet; S. Hoffmann; Lucie Fournier; M. Belloni; I. Jovanovic; T. Bah; Estelle Davesne; E. Blanchardon; C. Challeton-de Vathaire; D. Laurier; Olivier Laurent
Radioprotection | 2015
A. Desbrée; M. Guyot; Marcel Ricard; D. Franck; B. Aubert; C. Challeton-de Vathaire
Radioprotection | 2014
David Broggio; E. Navarro; D. Viltard; C. Challeton-de Vathaire; R. Bô; L. Debrose; X. Moya; D. Franck